Advanced solid tumor with lung and/or liver involvement

Clinical trials for Advanced solid tumor with lung and/or liver involvement explained in plain language.

Never miss a new study

Get alerted when new Advanced solid tumor with lung and/or liver involvement trials appear

Sign up with your email to follow new studies for Advanced solid tumor with lung and/or liver involvement, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a nanoparticle deliver chemo more safely to Hard-to-Treat cancers?

Disease control Not yet recruiting

This trial is testing an experimental drug called ML-016, a nanoparticle form of the chemotherapy doxorubicin, in people with advanced solid tumors that have spread to the lungs or liver. The study aims to find the safest dose and see whether the drug can shrink tumors or slow th…

Matched conditions: ADVANCED SOLID TUMOR WITH LUNG AND/OR LIVER INVOLVEMENT

Phase 1/2 • Sponsor: BrYet US, Inc. • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC

Advanced solid tumor with lung and/or liver involvement

Get alerted when new Advanced solid tumor with lung and/or liver involvement trials appear

Can a nanoparticle deliver chemo more safely to Hard-to-Treat cancers?